Moors, Tim E.
Mona, Daniel
Luehe, Stefan
Duran-Pacheco, Gonzalo
Spycher, Liz
Mundigl, Olaf
Kaluza, Klaus
Huber, Sylwia
Hug, Melanie N.
Kremer, Thomas
Ritter, Mirko
Dziadek, Sebastian
Dernick, Gregor
van de Berg, Wilma D. J.
Britschgi, Markus http://orcid.org/0000-0001-6151-4257
Funding for this research was provided by:
Roche
Article History
Received: 15 March 2022
Accepted: 16 May 2022
First Online: 3 June 2022
Declarations
:
: Postmortem human brain tissue from clinically diagnosed and neuropathologically verified donors with advanced PD as well as non-demented controls was collected by the Netherlands Brain Bank (ExternalRef removed). In compliance with all local ethical and legal guidelines, informed consent for brain autopsy and the use of brain tissue and clinical information for scientific research was given by either the donor or the next of kin. A reference to the published Code of Conduct for brain banking of NBB is provided in the text [CitationRef removed]. The procedures of the Netherlands Brain Bank (Amsterdam, The Netherlands) were approved by the Institutional Review Board and Medical Ethical Board (METC) from the VU University Medical Center (VUmc), Amsterdam.
: All authors have read the manuscript and indicated consent for publication.
: The authors declare no competing interests. T.E.M., D.M., S.L., G. D., L. S., O.M., K.K., S.H., M.H., T.K., M.R., S.D., G.D. and M.B. are or were full-time employees of Roche/F. Hoffmann-La Roche Ltd, and they may additionally hold Roche stock/stock options.